Regional hippocampal atrophy in multiple sclerosis.

Gray matter brain structures, including deep nuclei and the cerebral cortex, are affected significantly and early in the course of multiple sclerosis and these changes may not be directly related to demyelinating white matter lesions. The hippocampus is an archicortical structure that is critical for memory functions and is especially sensitive to multiple insults including inflammation. We used high-resolution MR imaging at 3.0 T to measure hippocampal volumes in relapsing remitting MS (RRMS) and secondary progressive MS (SPMS) patients and controls. We found that both groups of MS patients had hippocampal atrophy and that this volume loss was in excess of global brain atrophy. Subregional analysis revealed selective volume loss in the cornu ammonis (CA) 1 region of the hippocampus in RRMS with further worsening of CA1 loss and extension into other CA regions in SPMS. Hippocampal atrophy was not correlated with T2-lesion volumes, and right and left hippocampi were affected equally. Volume loss in the hippocampus and subregions was correlated with worsening performance on word-list learning, a task requiring memory encoding, but not with performance on the Paced Auditory Serial Addition Task (PASAT), a test of information processing speed. Our findings provide evidence for selective and progressive hippocampal atrophy in MS localized initially to the CA1 subregion that is associated with deficits in memory encoding and retrieval. The underlying histopathological substrate for this selective, symmetric and disproportionate regional hippocampal vulnerability remains speculative at this time. Further understanding of this process could provide targets for therapeutic interventions including neuroprotective treatments.

[1]  Frederik Barkhof,et al.  In vivo MR imaging of hippocampal lesions in multiple sclerosis , 2008, Journal of magnetic resonance imaging : JMRI.

[2]  R. Clark,et al.  The medial temporal lobe. , 2004, Annual review of neuroscience.

[3]  G. Mangun,et al.  Successful Verbal Encoding into Episodic Memory Engages the Posterior Hippocampus: A Parametrically Analyzed Functional Magnetic Resonance Imaging Study , 1998, The Journal of Neuroscience.

[4]  Richard M. Leahy,et al.  BrainSuite: An Automated Cortical Surface Identification Tool , 2000, MICCAI.

[5]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[6]  R. Sapolsky,et al.  Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures , 2005, Experimental Neurology.

[7]  F Träber,et al.  Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. , 2007, AJNR. American journal of neuroradiology.

[8]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[9]  N. Sousa,et al.  Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-d-aspartate receptors , 2003, Neuroscience.

[10]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[11]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[12]  V. Haughton,et al.  Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.

[13]  G. Chrousos,et al.  Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. , 1994, The Journal of clinical endocrinology and metabolism.

[14]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[15]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[16]  D. Amaral,et al.  Hippocampal‐neocortical interaction: A hierarchy of associativity , 2000, Hippocampus.

[17]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[18]  C. Conrad,et al.  What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? , 2006, Behavioral and cognitive neuroscience reviews.

[19]  Á. Simonyi,et al.  Kainic acid-mediated excitotoxicity as a model for neurodegeneration , 2007, Molecular Neurobiology.

[20]  P. Jezzard,et al.  Thalamic neurodegeneration in relapsing-remitting multiple sclerosis , 2003, Neurology.

[21]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[22]  N. Raz,et al.  Memory in multiple sclerosis: Contextual encoding deficits , 2002, Journal of the International Neuropsychological Society.

[23]  Uhc Campus Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study , 2005 .

[24]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[25]  B. Giordani,et al.  Improvement in learning associated with increase in hippocampal formation volume , 2003, Biological Psychiatry.

[26]  A Achiron,et al.  Cognitive impairment in probable multiple sclerosis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[27]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[28]  D. Ecker,et al.  Reversible impaired memory induced by pulsed methylprednisolone in patients with MS , 2005, Neurology.

[29]  D. Price,et al.  Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[30]  Frederik Barkhof,et al.  MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis , 2006, Magnetic resonance in medicine.

[31]  F. Holsboer,et al.  Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation , 2005, Molecular Psychiatry.

[32]  D. Amaral,et al.  The Hippocampal Formation , 2009 .

[33]  R. Brunner,et al.  Effect of corticosteroids on short-term and long-term memory , 2005, Neurology.

[34]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[35]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[36]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[37]  P M Thompson,et al.  Unfolding the human hippocampus with high resolution structural and functional MRI , 2001, The Anatomical record.

[38]  G. York Personal history , 2005, Neurology.

[39]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[40]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[41]  J. Fischer,et al.  Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. , 2001, Archives of neurology.

[42]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[43]  B. Anderson,et al.  Synapse loss from chronically elevated glucocorticoids: Relationship to neuropil volume and cell number in hippocampal area CA3 , 2006, The Journal of comparative neurology.

[44]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[45]  David G. Amaral,et al.  21 – Hippocampal Formation , 1990 .

[46]  R. Ravid,et al.  Increased expression and function of glutamate transporters in multiple sclerosis , 2006, Neurobiology of Disease.